Newsfeeds - Spark Newswire

2 minute read

Earnings

ADMA Biologics’s Return On Capital Employed Overview

Today, 10:01 AM

According to data from Benzinga Pro, during Q4, ADMA Biologics's (NASDAQ:ADMA) reported sales totaled $26.38 million. Despite a 6.0% increase in earnings, the company posted a loss of $16.65 million.

ADMA

1 minute read

ADMA Biologics’ Q4 Top-Line Surpass Estimates, Concludes $175M Debt Refinancing

By Vandana Singh

Today, 10:01 AM

ADMA Biologics Inc (NASDAQ: ADMA) closed a debt refinancing with Hayfin Capital Management of $150 million, and up to an additional $25 million tied to specific revenue targets during 2022.

ADMA

5 minute read

Earnings Scheduled For March 24, 2022

By Benzinga Insights

Today, 10:01 AM

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter.

ADMA

1 minute read

Earnings

ADMA Biologics’s Earnings Outlook

By Benzinga Insights

Today, 10:01 AM

ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that ADMA Biologics will report an earnings per share (EPS) of $-0.09.

ADMA

2 minute read

ADMA BioCenters Receives FDA Approval For Its Fifth Plasma Collection Center, Located In Conyers, GA

By Benzinga Newsdesk

Today, 10:01 AM

ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it

ADMA

1 minute read

ADMA Biologics Shares Gain As Interim Q4 Sales Beat Expectation

By Vandana Singh

Today, 10:01 AM

ADMA Biologics Inc (NASDAQ: ADMA) expects

ADMA

2 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 10:01 AM

ADMA

2 minute read

News

ADMA Biologics Provides Update On Global Intellectual Property Portfolio

By Benzinga Newsdesk

Today, 10:01 AM

ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived

ADMA

7 minute read

91 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:01 AM

Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart stores nationwide.

ADMA

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 10:01 AM

Gainers

ADMA